
Shiv Cancer Institute Private Limited
Provides human health and social care services, including radiation therapy and oncology diagnostics.
Provides human health and social care services, including radiation therapy and oncology diagnostics.
Shiv Cancer Institute Private Limited (SCIPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 January 2014 and has a history of 11 years and two months. Its registered office is in Sangli, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹1.13 Cr. The company has closed loans amounting to ₹8.76 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sharad Desai and Leela Desai serve as directors at the Company.
Sangli, Maharashtra, India
+91-XXXXXXXXXX
U85100PN2014PTC150127
150127
Private Limited Indian Non-Government Company
10 Jan 2014
30 Sep 2024
31 Mar 2024
Unlisted
Roc Pune
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sharad Desai ![]() | Director | 10-Jan-2014 | Current |
Leela Desai ![]() | Director | 10-Jan-2014 | Current |
Shiv Cancer Institute Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.65% increase. The company also saw a substantial improvement in profitability, with a 373.44% increase in profit. The company's net worth Soared by an impressive increase of 21.37%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Shiv Cancer Institute had a promoter holding of 56.08% and a public holding of 43.93%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sharad Desai and Leela Desai are mutual person
₹1.13 Cr
₹8.76 Cr
Date | Lender | Amount | Status |
---|---|---|---|
02 Jul 2015 | Shri Veershaiv Co-Op Bank Ltd | ₹1.13 Cr | Open |
18 Feb 2017 | Tjsb Sahakari Bank Limited | ₹6.45 M | Satisfied |
07 Dec 2015 | Tjsb Sahakari Bank Limited | ₹1.22 M | Satisfied |
15 Oct 2015 | Tjsb Sahakari Bank Limited | ₹1.45 M | Satisfied |
29 Sep 2015 | Tjsb Sahakari Bank Limited | ₹1.20 Cr | Satisfied |
Unlock and access historical data on people associated with Shiv Cancer Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shiv Cancer Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shiv Cancer Institute's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shiv Cancer Institute Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Shiv Cancer Institute Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
A charge registered on 18 Feb 2017 via Charge ID 100082830 with Tjsb Sahakari Bank Limited was fully satisfied on 24 Mar 2021.
A charge registered on 07 Dec 2015 via Charge ID 10610580 with Tjsb Sahakari Bank Limited was fully satisfied on 24 Mar 2021.
A charge registered on 15 Oct 2015 via Charge ID 10600038 with Tjsb Sahakari Bank Limited was fully satisfied on 24 Mar 2021.
A charge registered on 29 Sep 2015 via Charge ID 10596492 with Tjsb Sahakari Bank Limited was fully satisfied on 24 Mar 2021.
Shiv Cancer Institute Private Limited was incorporated on 10 Jan 2014.
The authorized share capital of Shiv Cancer Institute Private Limited is ₹ 3.00 Cr and paid-up capital is ₹ 2.00 Cr.
Currently 2 directors are associated with Shiv Cancer Institute Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Shiv Cancer Institute Private Limited is 795/A 1/3A/1/4 Mahatma Gandhi Cancer Hospital Budhagaonkar Mala Shaskiya Dudh Dairy R D, Zari Bag India, Miraj, Maharashtra, 416410.
The corporate identification number (CIN) of Shiv Cancer Institute Private Limited is U85100PN2014PTC150127 and the company number is 150127 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Shiv Cancer Institute Private Limited has risen by 33.65%.
The financial reports for the fiscal year 2023 indicates that The net worth of Shiv Cancer Institute Private Limited has experienced an upsurge of 21.37%.
As per the financial statements for fiscal Year 2023, The total open charges for Shiv Cancer Institute Private Limited amount to ₹ 1.13 Cr.
The most recent Balance Sheet for Shiv Cancer Institute Private Limited was filed with the ROC on 31 Mar 2024.